Glucagon-like peptide-1 receptor agonists, commonly known as GLP-1 drugs, are a class of peptide medications ( not dietary supplements ) primarily used to treat type 2 diabetes (T2D) and obesity
CMS has indicated it intends to collect utilization data through the Bridge to inform future coverage decisions, but that data alone does not guarantee a successor program
Discontinue use and consult a healthcare provider if you experience: Severe allergic reactions (rash, difficulty breathing, swelling), persistent injection site infections, or any concerning symptoms that do not resolve
The medication reduces appetite and slows gastric emptying
Graves hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease
Semaglutide can be an effective tool for weight loss when used correctly